1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow Liver Inflammation: new trials by email Literature Review of Liver Inflammation trials Research Report on Liver Inflammation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis B Entecavir, Magnesium Isoglycyrrhizinate, Diammonium Glycyrrhizinate - Chronic Hepatitis b, Liver Inflammation | Phase 4 | Unknown | Cttq | 480 | 2017-11-25 | 2017-11-21 |
Hepatitis (1) · Hepatitis B, Chronic (1) · Liver Cirrhosis (1)
Blood-Borne Infections (1) · Chronic Disease (1) · Communicable Diseases (1) · DNA Virus Infections (1) · Digestive System Diseases (1) · Disease Attributes (1) · Fibrosis (1) · Hepadnaviridae Infections (1) · Hepatitis B (1) · Hepatitis, Chronic (1) · Hepatitis, Viral, Human (1) · Infections (1) · Liver Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate (1) · Glycyrrhizic Acid (1) · entecavir (1)
Cttq (1)